71 – 80 of 278
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus
(
- Contribution to journal › Article
-
Mark
Inhibition of Thrombin Formation by Active Site Mutated (S360A) Activated Protein C
(
- Contribution to journal › Article
-
Mark
The D2194G mutation is responsible for increased levels of FV1 in carriers of the factor V R2 haplotype
(
- Contribution to journal › Letter
-
Mark
ACTIVE PHOSPHOLIPID TRANSFER PROTEIN (PLTP) REDUCES PROTHROMBIN ACTIVATION AND ATTENUATES BLOOD COAGULATION
2010) 78th Congress of the European-Atherosclerosis-Society In Atherosclerosis Supplements 11(2). p.233-233(
- Contribution to journal › Published meeting abstract
-
Mark
Mouse ApoM Displays an Unprecedented Seven-Stranded Lipocalin Fold: Folding Decoy or Alternative Native Fold?
(
- Contribution to journal › Article
-
Mark
Umbilical cord plasma levels of growth-arrest specific protein 6 in intrauterine growth restriction
(
- Contribution to journal › Article
-
Mark
Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl as markers of large abdominal aortic aneurysms.
(
- Contribution to journal › Article
-
Mark
The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes.
(
- Contribution to journal › Article
-
Mark
Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia.
(
- Contribution to journal › Article
-
Mark
Plasma concentrations of apolipoproteins A-I, B, and M in patients with critical limb ischemia.
(
- Contribution to journal › Article